首页> 外文期刊>Annals of the New York Academy of Sciences >Characterization of Antibodies Directed against the Immunoglobulin Light K Chain Variable Chain Region (VK) of Hepatitis C Virus-Related Type-II Mixed Cryoglobulinemia and B-Cell Proliferations
【24h】

Characterization of Antibodies Directed against the Immunoglobulin Light K Chain Variable Chain Region (VK) of Hepatitis C Virus-Related Type-II Mixed Cryoglobulinemia and B-Cell Proliferations

机译:针对丙型肝炎病毒相关的II型混合球蛋白和B细胞增殖的免疫球蛋白轻K链可变链区(VK)的抗体的表征

获取原文
获取原文并翻译 | 示例
           

摘要

Autoimmune type-II cryoglobulinemia (II-MC) is sustained by hepatitis C virus (HGV) infection and B-cell (oligo)clones. This is the reason why the disease may be considered an "indolent B-cell lymphoma (NHL)." B clones show a restricted use of immunoglobulin variable genes (BCR), in particular in the use of the variable κ (VK)3-20/15 light chain, and show a homology between their BCR functional regions and those of autoimmune rheumatoid factors. We underlined the BCR unique repertoire with frequent rheumatoid factor activity also observed in other autoimmune disorders associated with NHL. The immunoglobulin idiotype is a clonal B-cell marker and an ideal target for immunother-apy. Five monoclonal antibodies were produced in our laboratory toward the VK3-20 of a subject with HCV infection and a II-MC-associated NHL. Epitope determination was performed using the epitope excision approach. Monoclonal antibody reactivity was tested in vitro in ELISA, Western blot, and cytofluorimetry. Data confirmed that a panel of antibodies, reactive against shared idiotypes, can be produced from patients with HCV-associated B-cell lymphoproliferative diseases, thus obviating the need to produce an anti-idiotype antibody for each patient.
机译:丙型肝炎病毒(HGV)感染和B细胞(寡聚)克隆可维持自身免疫性II型冰球蛋白血症(II-MC)。这就是为什么该疾病可被视为“惰性B细胞淋巴瘤(NHL)”的原因。 B克隆显示免疫球蛋白可变基因(BCR)的使用受到限制,特别是在可变κ(VK)3-20 / 15轻链的使用中,显示出其BCR功能区与自身免疫类风湿因子的同源性。我们强调了在经常与类风湿因子活性有关的BCR独特库中,也可在与NHL相关的其他自身免疫性疾病中观察到。免疫球蛋白的独特型是克隆的B细胞标记,是免疫治疗的理想靶标。在我们的实验室中,针对患有HCV感染和II-MC相关的NHL的受试者的VK3-20,产生了5种单克隆抗体。使用表位切除方法进行表位测定。在ELISA,Western印迹和细胞荧光法中体外测试了单克隆抗体的反应性。数据证实,可以从患有HCV相关B细胞淋巴增生性疾病的患者中产生与共有独特型具有反应性的一组抗体,从而避免了为每位患者产生抗独特型抗体的需要。

著录项

  • 来源
    《Annals of the New York Academy of Sciences》 |2009年第2009期|152-160|共9页
  • 作者单位

    Experimental and Clinical Pharmacology Unit, DOMERT, Molecular Oncology and Trans- lational Research Department, GRCX Ccntro di Rifcnmcnto Oncologico, IRCGS, National Cancer Institute, Franco Gallini, 2, 33081 Aviano (PN), Italy;

    Experimental and Clinical Pharmacology Unit, Dipartimento di Oncologia Molecolare e Ricerca Traslazionale, Aviano Italy;

    Experimental and Clinical Pharmacology Unit, Dipartimento di Oncologia Molecolare e Ricerca Traslazionale, Aviano Italy;

    Experimental and Clinical Pharmacology Unit, Dipartimento di Oncologia Molecolare e Ricerca Traslazionale, Aviano Italy;

    Experimental and Clinical Pharmacology Unit, Dipartimento di Oncologia Molecolare e Ricerca Traslazionale, Aviano Italy;

    Cancer Bio-Immunotherapy Unit, Centro di Riferimento Oncologico, Istituto Di Ricovero e Cura a Carattere Sdentifico, National Cancer Institute, Aviano Italy;

    Clinic of Rheumatology Azienda Ospedaliera-University of Udine, Italy;

    Department of Internal Medicine and Clinical Oncology, University of Bart, Italy;

    Department of Chemical Sciences, University of Trieste, Italy;

    Experimental and Clinical Pharmacology Unit, Dipartimento di Oncologia Molecolare e Ricerca Traslazionale, Aviano Italy;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    HCV; idiotype; single-chain immunoglobulin variable fragment; mono- clonal antibody; type II mixed cryoglobulinemia; NHL; lymphoma;

    机译:丙型肝炎病毒;独特型单链免疫球蛋白可变片段;单克隆抗体;II型混合性冷球蛋白血症;NHL;淋巴瘤;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号